Manufacturers Life Insurance Company, The Uro Gen Pharma Ltd. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 37,486 shares of URGN stock, worth $403,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,486
Previous 13,480
178.09%
Holding current value
$403,724
Previous $171,000
133.33%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding URGN
# of Institutions
138Shares Held
39.1MCall Options Held
9.8KPut Options Held
49.2K-
Rtw Investments, LP New York, NY3.83MShares$41.3 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$31.5 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.8 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.6 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$18.8 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $245M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...